(Q42627816)

4 November 2017

Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial (English)

1 reference

multicenter clinical trial

4 November 2017

0 references

0 references

Patrick McNamara

9

0 references

Canadian Critical Care Trials Group

11

object named as

Canadian Critical Care Trials Group

1 reference

4 November 2017

Karen Choong

1

1 reference

4 November 2017

Desmond Bohn

2

1 reference

4 November 2017

Douglas D Fraser

3

1 reference

4 November 2017

Isabelle Gaboury

4

1 reference

4 November 2017

James S Hutchison

5

1 reference

4 November 2017

Ari R Joffe

6

1 reference

4 November 2017

Catherine Litalien

7

1 reference

4 November 2017

Kusum Menon

8

1 reference

4 November 2017

Roxanne E Ward

10

1 reference

4 November 2017

language of work or name

English

0 references

publication date

16 July 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

4 November 2017

1 reference

4 November 2017

180

1 reference

4 November 2017

7

1 reference

4 November 2017

632-639

1 reference

The epidemiology of severe sepsis in children in the United States.

4 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Review article: organ perfusion/permeability-related effects of norepinephrine and vasopressin in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Too much of a good thing? Epinephrine on trial!

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Catecholamines and vasopressin during critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Vasopressin in pediatric shock and cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

The pathogenesis of vasodilatory shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Science review: Vasopressin and the cardiovascular system part 1--receptor physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

The vasopressin and copeptin response to infection, severe sepsis, and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Vasopressin in vasodilatory and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Beneficial effects of short-term vasopressin infusion during severe septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Vasopressin in catecholamine-refractory shock in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Hemodynamic support in fluid-refractory pediatric septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

PRISM III: an updated Pediatric Risk of Mortality score

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Charting the course of critical illness: prognostication and outcome description in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Human platelet fraction arginine-vasopressin. Potential physiological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

A comparison of sample size methods for the logrank statistic

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Vasopressin versus norepinephrine infusion in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Vasopressin analogues in the treatment of shock states: potential pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Terlipressin for catecholamine-resistant septic shock in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Copeptin: clinical use of a new biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Pediatric critical care medicine: planning for our research future

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Collaborative Pediatric Critical Care Research Network (CPCCRN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Supplemental inhaled gases alter tidal volume delivery and measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200902-0221OC

10.1164/RCCM.200902-0221OC

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference